Mindful Eating and Current Glycemic Control in Patients With Type 2 Diabetes
Launched by GOZTEPE PROF DR SULEYMAN YALCIN CITY HOSPITAL · Jan 26, 2024
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
In type 2 diabetes, life style adaptations, mainly healthy eating, weight loss or control and exercise constitutes the foundation of type 2 diabetes management. In addition to regulating blood sugar levels, lifestyle modifications play a significant role in controlling risk factors such as hypertension and hyperlipidemia, delaying/preventing complications from developing, and even promoting diabetes regression. It is essential not only to focus on healthy food choices in dietary therapy but also to ensure patients achieve weight loss. Another crucial point is maintaining the continuity of t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • given consent to the study
- • having applied to Diabetes Outpatient Clinic for diabetes management
- • having diagnosed with type 2 diabetes for at least 6 months
- • having the mental competence to answer the questions in the questionnaire
- Exclusion Criteria:
- • Inconclusive diagnosis of type 2 diabetes
- • having not received or not using any treatment for diabetes
About Goztepe Prof Dr Suleyman Yalcın City Hospital
Goztepe Prof. Dr. Suleyman Yalcın City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Renowned for its state-of-the-art facilities and multidisciplinary approach, the hospital focuses on a wide range of therapeutic areas, fostering collaboration among healthcare professionals to ensure high standards of care and ethical research practices. Committed to enhancing medical knowledge, Goztepe City Hospital plays a pivotal role in bringing groundbreaking treatments to the forefront of clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Ayşe N Erbakan, MD
Principal Investigator
Istanbul Medeniyet University Goztepe Prof Dr Suleyman Yalcın City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported